Impact of the availability of active cytotoxic agents on the survival of patients with advanced gastric cancer

Author：

E-ISSN： 1792-1082|10|4|2481-2486

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.4, 2015-01, pp. : 2481-2486

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Availability of irinotecan in a second-line setting confers survival benefit to patients with advanced gastric cancer refractory to fluoropyrimidine-based regimens

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 247-251

Spandidos Publications

Access to resources Recommend Favorite

Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer

By Shitara Kohei

Gastric Cancer, Vol. 14, Iss. 2, 2011-06 ,pp. : 155-160

Springer Publishing Company

Access to resources Recommend Favorite

The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatinbased adjuvant chemotherapy

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 935-942

Spandidos Publications

Access to resources Recommend Favorite

Correlation between overall survival and other endpoints in clinical trials of second-line chemotherapy for patients with advanced gastric cancer

By Shitara Kohei Matsuo Keitaro Muro Kei Doi Toshihiko Ohtsu Atsushi

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 362-370

Springer Publishing Company

Access to resources Recommend Favorite

Socioeconomic status and survival of gastric cancer patients

By Fontana V. Decensi A. Orengo M.A. Parodi S. Torrisi R. Puntoni R.

European Journal of Cancer, Vol. 34, Iss. 4, 1998-03 ,pp. : 537-542

Elsevier

Access to resources Recommend Favorite